
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Feb 08, 2026 00:59 am UTC| Business Health Governance
Hims Hers Health announced on Saturday that it will stop offering access to its compounded semaglutide pill following a warning from the U.S. Food and Drug Administration, which said it would take action against the...

Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Feb 08, 2026 00:54 am UTC| Politics Business
U.S. President Donald Trump has publicly endorsed a proposed merger between Nexstar Media Group and Tegna, signaling renewed political attention on the future of local television broadcasting. In a post shared Saturday on...

Washington Post Publisher Will Lewis Steps Down After Layoffs
Feb 08, 2026 00:46 am UTC| Business
Washington Post publisher and CEO Will Lewis announced that he is stepping down from his role, according to a message shared with staff and later posted publicly by White House bureau chief Matt Viser on Saturday. The...

American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Feb 08, 2026 00:45 am UTC| Business
American Airlines CEO Robert Isom has said he is prepared to meet with the companys pilots union as soon as possible, following growing concerns from aviators about the airlines operational decisions, financial...

Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Feb 08, 2026 00:42 am UTC| Health Business
Pharmaceutical and telehealth companies are spending millions of dollars on celebrity-driven Super Bowl ads as competition heats up in the fast-growing weight-loss drug market. Brands behind GLP-1 weight-loss medications,...

Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Feb 07, 2026 03:36 am UTC| Business
Toyota Motor Corp., the worlds largest automaker by sales, has announced an unexpected leadership change at a time when the global automotive industry is facing mounting challenges. The Japanese carmaker said it will...

FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Feb 07, 2026 03:05 am UTC| Governance Health Business
The U.S. Food and Drug Administration (FDA) announced on Friday that it will take enforcement action against telehealth provider Hims Hers over its $49 weight-loss pill, escalating scrutiny of compounded GLP-1 drugs sold...